Cell name:
OCI-LY7
Other names for the model:
OCI-Ly7、OCI-LY-7 、OCI-Ly-7、Oci-Ly-7、OCI-Ly 7、OCI-Ly07、OCILY7、Ly7、LY7
Cell information:
OCI-LY7 cells are derived from human diffuse large B lymphoma and are often used for screening BCL-6 inhibitors. Click to view More information.
Model information:
5X106 OCI-LY7 cells per mouse are mixed with Matri-gel and inoculated into right flank region in NOD SCID mice.
About 14 days post inoculation, the mice can be grouped, with average tumor volumes at 150-250 m3.
The duration of treatment is about 20 days post grouping (when the tumor volumes in the vehicle group reach 2000 m3).
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059